Work

Vorinostat Synergistically Potentiates MK-0457 Lethality in Chronic Myelogenous Leukemia (CML) Cells Sensitive and Resistant to Imatinib Mesylate.

FWCI: 0.567
Cites:
Cited by: 3
Related to: 10